Tamborrini M, Schäfer A, Hauser J, Zou L, Paris D.H, Pluschke G. The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals. Malar J. 2023;22:210. DOI: 10.1186/s12936-023-04638-8

2023
Journal Article
PubMed

Fernandes B, Sousa M, Castro R, Schäfer A, Hauser J, Schulze K, Amacker M, Tamborrini M, Pluschke G, Alves P.M, Fleury S, Roldão A. Scalable process for high-yield production of PfCyRPA using insect cells for inclusion in a malaria virosome-based vaccine candidate. Front Bioeng Biotechnol. 2022;10:879078. DOI: 10.3389/fbioe.2022.87907

2022
Journal Article
PubMed

Tamborrini M, Hauser J, Schäfer A, Amacker M, Favuzza P, Kyungtak K, Fleury S, Pluschke G. Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models. Vaccines. 2020;5:9. DOI: 10.1038/s41541-020-0158-9

2020
Journal Article
PubMed

Röltgen K, Rose N, Ruggieri A, Warryn L, Scherr N, Pinho-Nascimento C.A, Tamborrini M, Jaenisch T, Pluschke G. Development of dengue virus serotype-specific NS1 capture assays for the rapid and highly sensitive identification of the infecting serotype in human sera. J Immunol. 2018;200(200):3857-3866. DOI: 10.4049/jimmunol.1701790

2018
Journal Article
PubMed

Bertolotti A, Haas P, Haueter I, Käser M, Kronig M, Mörgeli S, Schwarz S, Tamborrini M, Waser M. Umfrage zur Kundenzufriedenheit und zum Verbesserungs-Potential der Administration – Schlussbericht. Basel: Swiss Tropical and Public Health Institute, 2017

2017
Report

Favuzza P, Guffart E, Tamborrini M, Scherer B, Dreyer A.M, Rufer A.C, Erny J, Hoernschemeyer J, Thoma R, Schmid G, Gsell B, Lamelas A, Benz J, Joseph C, Matile H, Pluschke G, Rudolph M.G. Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody. Elife. 2017;6:e20383. DOI: 10.7554/eLife.20383

2017
Journal Article
PubMed

Favuzza P, Blaser S, Dreyer A.M, Riccio G, Tamborrini M, Thoma R, Matile H, Pluschke G. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA. Malar J. 2016;15:161. DOI: 101.1186/s12936-016-1213-x

2016
Journal Article
PubMed

Rose N, Pinho-Nascimento C.A, Ruggieri A, Favuzza P, Tamborrini M, Roth H, Baroni de Moraes M.T, Matile H, Janisch T, Pluschke G, Roltgen K. Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization. BMC Biotechnol. 2016;16:83. DOI: 10.1186/s12896-016-0314-5

2016
Journal Article
PubMed

Favuzza P, Blaser S, Dreyer A, Tamborrini M, Matile H, Pluschke G. Novel approaches for the identification and profiling of new Plasmodium falciparum antigens as promising blood-stage candidates for inclusion in a malaria subunit vaccine. Trop Med Int Health, 2015;20(Suppl. 1):20-21

2015
Conference Paper

Silbereisen A, Tamborrini M, Wittwer M, Schürch N, Pluschke G. Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species. BMC Microbiol. 2015;15:198. DOI: 10.1186/s12866-015-0534-1

2015
Journal Article
PubMed

Silbereisen A, Tamborrini M, Wittwer M, Urch N.S, Pluschke G. Development of a bead-based Luminex assay using lipopolysacharide specific monoclonal antibodies for the detection of bio threat Brucella species. Trop Med Int Health, 2015;20(Suppl. 1):394

2015
Conference Paper

Tamborrini M, Geib N, Marrero-Nodarse A, Jud M, Hauser J, Aho C, Lamelas A, Zuniga A, Pluschke G, Ghasparian A, Robinson J.A. A synthetic virus-like particle streptococcal vaccine candidate using B-cell epitopes from the proline-rich region of pneumococcal surface protein A. Vaccine. 2015;3(4):850-874. DOI: 10.3390/vaccines3040850

2015
Journal Article
PubMed

Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, Poetz O, Pluschke G, Gertsch J. Identification and qualification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem. 2012;287(44):36944-36967. DOI: 10.1074/jbc.M112.382481

2012
Journal Article
PubMed

Pluschke G, Tamborrini M. Development of a virosomal malaria vaccine candidate: from synthetic peptide design to clinical concept validation. Future Virol. 2012;7(8):779-790. DOI: 10.2217/fvl.12.74

2012
Journal Article

Ghasparian A, Riedel T, Koomullil J, Moehle K, Gorba C, Svergun D.I, Perriman A.W, Mann S, Tamborrini M, Pluschke G, Robinson J.A. Engineered synthetic virus-like particles and their use in vaccine delivery. ChemBioChem. 2011;12(1):100-109. DOI: 10.1002/cbic.201000536

2011
Journal Article
PubMed

Tamborrini M, Bauer M, Bolz M, Maho A, Oberli M.A, Werz D.B, Schelling E, Zinsstag J, Seeberger P.H, Frey J, Pluschke G. Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface associated anthrose containing oligosaccharide. J Bacteriol. 2011;193(14):3506-3511. DOI: 10.1128/JB.00078-11

2011
Journal Article
PubMed

Tamborrini M, Stoffel S.A, Westerfeld N, Amacker M, Theisen M, Zurbriggen R, Pluschke G. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malar J. 2011;10:359. DOI: 10.1186/1475-2875-10-359

2011
Journal Article
PubMed

Oberli M.A, Tamborrini M, Tsai Y.H, Werz D.B, Horlacher T, Adibekian A, Gauss D, Möller H.M, Pluschke G, Seeberger P.H. Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. J Am Chem Soc. 2010;132(30):10239-10241. DOI: 10.1021/ja104027w

2010
Journal Article
PubMed

Pluschke G, Tamborrini M. Virosomal technology in malaria vaccine development. Future Virology. 2010;5(3):247-250. DOI: 10.2217/fvl.10.24

2010
Journal Article

Tamborrini M, Holzer M, Seeberger P.H, Schürch N, Pluschke G. Anthrax spore detection by a Luminex assay based on monoclonal antibodies recognizing anthrose-containing oligosaccharides. Clin Vaccine Immunol. 2010;17(9):1446-1451. DOI: 10.1128/CVI.00205-10

2010
Journal Article
PubMed

Tamborrini M, Liu X, Mugasa J.P, Kwon Y.U, Kamena F, Seeberger P.H, Pluschke G. Synthetic glycosylphosphatidylinositol microarray reveals differential antibody levels and fine specificities in children with mild and severe malaria. Bioorg Med Chem Lett. 2010;18:3747-3752. DOI: 10.1016/j.bmc.2010.04.059

2010
Journal Article
PubMed

Tamborrini M, Mueller M.S, Stoffel S.A, Westerfeld N, Vogel D, Boato F, Zurbriggen R, Robinson J.A, Pluschke G. Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine. Malar J. 2009;8:314. DOI: 10.1186/1475-2875-8-314

2009
Journal Article
PubMed

Tamborrini M, Oberli M.A, Werz D.B, Schürch N, Frey J, Seeberger P.H, Pluschke G. Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains. J Appl Microbiol. 2009;106(5):1618-1628

2009
Journal Article
PubMed

Tamborrini Marco. Use of synthetic carbohydrates as vaccine components and biomedical research tools. Basel: Univ. Basel, 2009. Doctoral Thesis, University of Basel, Faculty of Science DOI: 10.5451/unibas-004882238

2009
Thesis

Treeck M, Tamborrini M, Daubenberger C.A, Gilberger T.W, Voss T.S. Caught in action: mechanistic insights into antibody-mediated inhibition of Plasmodium merozoite invasion. Trends Parasitol. 2009;25(11):494-497. DOI: 10.1016/j.pt.2009.07.008

2009
Journal Article
PubMed

Kamena F, Tamborrini M, Liu X, Kwon Y.U, Thompson F, Pluschke G, Seeberger P.H. Synthetic GPI array to study antitoxic malaria response. Nat Chem Biol. 2008;4(4):238-240

2008
Journal Article
PubMed

Tamborrini M, Werz D.B, Frey J, Pluschke G, Seeberger P.H. Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed Engl. 2006;45(39):6581-6582

2006
Journal Article
PubMed